Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 312

1.

Restricted myeloperoxidase epitopes drive the adaptive immune response in MPO-ANCA vasculitis.

Free ME, Stember KG, Hess JJ, McInnis EA, Lardinois O, Hogan SL, Hu Y, Mendoza C, Le AK, Guseman AJ, Pilkinton MA, Bortone DS, Cowens K, Sidney J, Karosiene E, Peters B, James E, Kwok WW, Vincent BG, Mallal SA, Jennette JC, Ciavatta DJ, Falk RJ.

J Autoimmun. 2019 Aug 2:102306. doi: 10.1016/j.jaut.2019.102306. [Epub ahead of print]

PMID:
31383567
2.

Measuring Circulating Complement Activation Products in Myeloperoxidase- and Proteinase 3-Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.

Wu EY, McInnis EA, Boyer-Suavet S, Mendoza CE, Aybar LT, Kennedy KB, Poulton CJ, Henderson CD, Hu Y, Hogan SL, Hu P, Xiao H, Nachman PH, Jennette JC, Falk RJ, Bunch DO.

Arthritis Rheumatol. 2019 Nov;71(11):1894-1903. doi: 10.1002/art.41011. Epub 2019 Oct 8.

PMID:
31215772
3.

Understanding Long-term Remission Off Therapy in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.

Hogan SL, Nachman PH, Poulton CJ, Hu Y, Blazek LN, Free ME, Jennette JC, Falk RJ.

Kidney Int Rep. 2019 Jan 28;4(4):551-560. doi: 10.1016/j.ekir.2019.01.004. eCollection 2019 Apr.

4.

Health-related quality of life in glomerular disease.

Canetta PA, Troost JP, Mahoney S, Kogon AJ, Carlozzi N, Bartosh SM, Cai Y, Davis TK, Fernandez H, Fornoni A, Gbadegesin RA, Herreshoff E, Mahan JD, Nachman PH, Selewski DT, Sethna CB, Srivastava T, Tuttle KR, Wang CS, Falk RJ, Gharavi AG, Gillespie BW, Greenbaum LA, Holzman LB, Kretzler M, Robinson BM, Smoyer WE, Guay-Woodford LM, Reeve B, Gipson DS; CureGN Consortium.

Kidney Int. 2019 May;95(5):1209-1224. doi: 10.1016/j.kint.2018.12.018. Epub 2019 Feb 27.

PMID:
30898342
5.

Immunoglobulins G from patients with ANCA-associated vasculitis are atypically glycosylated in both the Fc and Fab regions and the relation to disease activity.

Lardinois OM, Deterding LJ, Hess JJ, Poulton CJ, Henderson CD, Jennette JC, Nachman PH, Falk RJ.

PLoS One. 2019 Feb 28;14(2):e0213215. doi: 10.1371/journal.pone.0213215. eCollection 2019.

6.

Clinical Characteristics and Treatment Patterns of Children and Adults With IgA Nephropathy or IgA Vasculitis: Findings From the CureGN Study.

Selewski DT, Ambruzs JM, Appel GB, Bomback AS, Matar RB, Cai Y, Cattran DC, Chishti AS, D'Agati VD, D'Alessandri-Silva CJ, Gbadegesin RA, Hogan JJ, Iragorri S, Jennette JC, Julian BA, Khalid M, Lafayette RA, Liapis H, Lugani F, Mansfield SA, Mason S, Nachman PH, Nast CC, Nester CM, Noone DG, Novak J, O'Shaughnessy MM, Reich HN, Rheault MN, Rizk DV, Saha MK, Sanghani NS, Sperati CJ, Sreedharan R, Srivastava T, Swiatecka-Urban A, Twombley K, Vasylyeva TL, Weaver DJ, Yin H, Zee J, Falk RJ, Gharavi AG, Gillespie BW, Gipson DS, Greenbaum LA, Holzman LB, Kretzler M, Robinson BM, Smoyer WE, Flessner M, Guay-Woodford LM, Kiryluk K; CureGN Consortium.

Kidney Int Rep. 2018 Aug 3;3(6):1373-1384. doi: 10.1016/j.ekir.2018.07.021. eCollection 2018 Nov.

7.

CureGN Study Rationale, Design, and Methods: Establishing a Large Prospective Observational Study of Glomerular Disease.

Mariani LH, Bomback AS, Canetta PA, Flessner MF, Helmuth M, Hladunewich MA, Hogan JJ, Kiryluk K, Nachman PH, Nast CC, Rheault MN, Rizk DV, Trachtman H, Wenderfer SE, Bowers C, Hill-Callahan P, Marasa M, Poulton CJ, Revell A, Vento S, Barisoni L, Cattran D, D'Agati V, Jennette JC, Klein JB, Laurin LP, Twombley K, Falk RJ, Gharavi AG, Gillespie BW, Gipson DS, Greenbaum LA, Holzman LB, Kretzler M, Robinson B, Smoyer WE, Guay-Woodford LM; CureGN Consortium.

Am J Kidney Dis. 2019 Feb;73(2):218-229. doi: 10.1053/j.ajkd.2018.07.020. Epub 2018 Nov 9.

PMID:
30420158
8.

Pathogenesis of ANCA-Associated Pulmonary Vasculitis.

Alba MA, Jennette JC, Falk RJ.

Semin Respir Crit Care Med. 2018 Aug;39(4):413-424. doi: 10.1055/s-0038-1673386. Epub 2018 Nov 7. Review.

9.

Inhibitory Anti-Peroxidasin Antibodies in Pulmonary-Renal Syndromes.

McCall AS, Bhave G, Pedchenko V, Hess J, Free M, Little DJ, Baker TP, Pendergraft WF 3rd, Falk RJ, Olson SW, Hudson BG.

J Am Soc Nephrol. 2018 Nov;29(11):2619-2625. doi: 10.1681/ASN.2018050519. Epub 2018 Oct 2.

10.

Eosinophilic Granulomatosis with Polyangiitis: Clinical Pathology Conference and Review.

Wu EY, Hernandez ML, Jennette JC, Falk RJ.

J Allergy Clin Immunol Pract. 2018 Sep - Oct;6(5):1496-1504. doi: 10.1016/j.jaip.2018.07.001. Review.

PMID:
30197069
11.

Case 24-2018: A 71-Year-Old Man with Acute Renal Failure and Hematuria.

Falk RJ, Husseini JS, Fenves AZ, Rosales IA.

N Engl J Med. 2018 Aug 9;379(6):568-578. doi: 10.1056/NEJMcpc1802829. No abstract available.

PMID:
30089061
12.

Nomenclature of Cutaneous Vasculitis: Dermatologic Addendum to the 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides.

Sunderkötter CH, Zelger B, Chen KR, Requena L, Piette W, Carlson JA, Dutz J, Lamprecht P, Mahr A, Aberer E, Werth VP, Wetter DA, Kawana S, Luqmani R, Frances C, Jorizzo J, Watts JR, Metze D, Caproni M, Alpsoy E, Callen JP, Fiorentino D, Merkel PA, Falk RJ, Jennette JC.

Arthritis Rheumatol. 2018 Feb;70(2):171-184. doi: 10.1002/art.40375. Review.

13.

Interstital lung disease in ANCA vasculitis.

Alba MA, Flores-Suárez LF, Henderson AG, Xiao H, Hu P, Nachman PH, Falk RJ, Charles Jennette J.

Autoimmun Rev. 2017 Jul;16(7):722-729. doi: 10.1016/j.autrev.2017.05.008. Epub 2017 May 4. Review.

14.

Temporal and Demographic Trends in Glomerular Disease Epidemiology in the Southeastern United States, 1986-2015.

O'Shaughnessy MM, Hogan SL, Poulton CJ, Falk RJ, Singh HK, Nickeleit V, Jennette JC.

Clin J Am Soc Nephrol. 2017 Apr 3;12(4):614-623. doi: 10.2215/CJN.10871016. Epub 2017 Mar 21.

15.

The Evolving Role of Rituximab in Adult Minimal Change Glomerulopathy.

Brown LC, Jobson MA, Payan Schober F, Chang EH, Falk RJ, Nachman PH, Pendergraft WF.

Am J Nephrol. 2017;45(4):365-372. doi: 10.1159/000464475. Epub 2017 Mar 18.

16.

Clinical Features and Outcomes of a Racially Diverse Population with Fibrillary Glomerulonephritis.

Payan Schober F, Jobson MA, Poulton CJ, Singh HK, Nickeleit V, Falk RJ, Jennette JC, Nachman PH, Pendergraft Iii WF.

Am J Nephrol. 2017;45(3):248-256. doi: 10.1159/000455390. Epub 2017 Feb 4.

17.

Identification of Functional and Expression Polymorphisms Associated With Risk for Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis.

Merkel PA, Xie G, Monach PA, Ji X, Ciavatta DJ, Byun J, Pinder BD, Zhao A, Zhang J, Tadesse Y, Qian D, Weirauch M, Nair R, Tsoi A, Pagnoux C, Carette S, Chung S, Cuthbertson D, Davis JC Jr, Dellaripa PF, Forbess L, Gewurz-Singer O, Hoffman GS, Khalidi N, Koening C, Langford CA, Mahr AD, McAlear C, Moreland L, Seo EP, Specks U, Spiera RF, Sreih A, St Clair EW, Stone JH, Ytterberg SR, Elder JT, Qu J, Ochi T, Hirano N, Edberg JC, Falk RJ, Amos CI, Siminovitch KA; Vasculitis Clinical Research Consortium.

Arthritis Rheumatol. 2017 May;69(5):1054-1066. doi: 10.1002/art.40034. Epub 2017 Apr 6.

18.

Gene-Specific DNA Methylation Changes Predict Remission in Patients with ANCA-Associated Vasculitis.

Jones BE, Yang J, Muthigi A, Hogan SL, Hu Y, Starmer J, Henderson CD, Poulton CJ, Brant EJ, Pendergraft WF 3rd, Jennette JC, Falk RJ, Ciavatta DJ.

J Am Soc Nephrol. 2017 Apr;28(4):1175-1187. doi: 10.1681/ASN.2016050548. Epub 2016 Nov 7.

19.

Histone modification signature at myeloperoxidase and proteinase 3 in patients with anti-neutrophil cytoplasmic autoantibody-associated vasculitis.

Yang J, Ge H, Poulton CJ, Hogan SL, Hu Y, Jones BE, Henderson CD, McInnis EA, Pendergraft WF 3rd, Jennette JC, Falk RJ, Ciavatta DJ.

Clin Epigenetics. 2016 Aug 12;8:85. doi: 10.1186/s13148-016-0251-0. eCollection 2016.

20.

Overview of the Pathogenesis of ANCA-Associated Vasculitis.

Xiao H, Hu P, Falk RJ, Jennette JC.

Kidney Dis (Basel). 2016 Mar;1(4):205-15. doi: 10.1159/000442323. Epub 2015 Dec 3. Review.

21.

Renal Survival in Patients with Collapsing Compared with Not Otherwise Specified FSGS.

Laurin LP, Gasim AM, Derebail VK, McGregor JG, Kidd JM, Hogan SL, Poulton CJ, Detwiler RK, Jennette JC, Falk RJ, Nachman PH.

Clin J Am Soc Nephrol. 2016 Oct 7;11(10):1752-1759. doi: 10.2215/CJN.13091215. Epub 2016 Jul 21.

22.

The Search for a Biomarker of Relapse in ANCA-Associated Vasculitis.

Free ME, Falk RJ.

J Am Soc Nephrol. 2016 Sep;27(9):2551-3. doi: 10.1681/ASN.2016030347. Epub 2016 May 9. No abstract available.

23.

Predictors of 30-Day Hospital Readmission among Maintenance Hemodialysis Patients: A Hospital's Perspective.

Flythe JE, Katsanos SL, Hu Y, Kshirsagar AV, Falk RJ, Moore CR.

Clin J Am Soc Nephrol. 2016 Jun 6;11(6):1005-14. doi: 10.2215/CJN.11611115. Epub 2016 May 5.

24.

Overcoming Barriers in Kidney Health-Forging a Platform for Innovation.

Linde PG, Archdeacon P, Breyer MD, Ibrahim T, Inrig JK, Kewalramani R, Lee CC, Neuland CY, Roy-Chaudhury P, Sloand JA, Meyer R, Smith KA, Snook J, West M, Falk RJ.

J Am Soc Nephrol. 2016 Jul;27(7):1902-10. doi: 10.1681/ASN.2015090976. Epub 2016 Apr 28.

25.

Patients with primary membranous nephropathy are at high risk of cardiovascular events.

Lee T, Derebail VK, Kshirsagar AV, Chung Y, Fine JP, Mahoney S, Poulton CJ, Lionaki S, Hogan SL, Falk RJ, Cattran DC, Hladunewich M, Reich HN, Nachman PH.

Kidney Int. 2016 May;89(5):1111-1118. doi: 10.1016/j.kint.2015.12.041. Epub 2016 Feb 26.

26.

Treatment with Glucocorticoids or Calcineurin Inhibitors in Primary FSGS.

Laurin LP, Gasim AM, Poulton CJ, Hogan SL, Jennette JC, Falk RJ, Foster BJ, Nachman PH.

Clin J Am Soc Nephrol. 2016 Mar 7;11(3):386-94. doi: 10.2215/CJN.07110615. Epub 2016 Feb 16.

27.

Trends in Long-Term Outcomes Among Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis With Renal Disease.

Rhee RL, Hogan SL, Poulton CJ, McGregor JA, Landis JR, Falk RJ, Merkel PA.

Arthritis Rheumatol. 2016 Jul;68(7):1711-20. doi: 10.1002/art.39614.

28.

Clinical Features of Reported Ethylene Glycol Exposures in the United States.

Jobson MA, Hogan SL, Maxwell CS, Hu Y, Hladik GA, Falk RJ, Beuhler MC, Pendergraft WF 3rd.

PLoS One. 2015 Nov 13;10(11):e0143044. doi: 10.1371/journal.pone.0143044. eCollection 2015.

29.

Nursing Intervention Aimed at Improving Self-Managementfor Persons with Chronic Kidney Disease in North Carolina Medicaid: A Pilot Project.

Vann JC, Hawley J, Wegner S, Falk RJ, Harward DH, Kshirsagar AV.

Nephrol Nurs J. 2015 May-Jun;42(3):239-55; quiz 256.

PMID:
26207285
30.

Gleaning relapse risk from B cell phenotype: decreased CD5+ B cells portend a shorter time to relapse after B cell depletion in patients with ANCA-associated vasculitis.

Bunch DO, Mendoza CE, Aybar LT, Kotzen ES, Colby KR, Hu Y, Hogan SL, Poulton CJ, Schmitz JL, Falk RJ, Nachman PH, Pendergraft WF, McGregor JG.

Ann Rheum Dis. 2015 Sep;74(9):1784-6. doi: 10.1136/annrheumdis-2014-206756. Epub 2015 Apr 30. No abstract available.

31.

Associations of Posthemodialysis Weights above and below Target Weight with All-Cause and Cardiovascular Mortality.

Flythe JE, Kshirsagar AV, Falk RJ, Brunelli SM.

Clin J Am Soc Nephrol. 2015 May 7;10(5):808-16. doi: 10.2215/CJN.10201014. Epub 2015 Apr 10.

32.

Autoimmunity to the alpha 3 chain of type IV collagen in glomerulonephritis is triggered by 'autoantigen complementarity'.

Reynolds J, Preston GA, Pressler BM, Hewins P, Brown M, Roth A, Alderman E, Bunch D, Jennette JC, Cook HT, Falk RJ, Pusey CD.

J Autoimmun. 2015 May;59:8-18. doi: 10.1016/j.jaut.2015.01.003. Epub 2015 Apr 2.

33.

Adverse events and infectious burden, microbes and temporal outline from immunosuppressive therapy in antineutrophil cytoplasmic antibody-associated vasculitis with native renal function.

McGregor JG, Negrete-Lopez R, Poulton CJ, Kidd JM, Katsanos SL, Goetz L, Hu Y, Nachman PH, Falk RJ, Hogan SL.

Nephrol Dial Transplant. 2015 Apr;30 Suppl 1:i171-81. doi: 10.1093/ndt/gfv045.

34.

Rituximab as an immunosuppressant in antineutrophil cytoplasmic antibody-associated vasculitis.

McGregor JG, Hogan SL, Kotzen ES, Poulton CJ, Hu Y, Negrete-Lopez R, Kidd JM, Katsanos SL, Bunch DO, Nachman PH, Falk RJ.

Nephrol Dial Transplant. 2015 Apr;30 Suppl 1:i123-31. doi: 10.1093/ndt/gfv076.

35.

What Everybody is Doing but No One is Talking About: Use of Complementary and Alternative Medicine in the ANCA Associated Vasculitis Population.

Berg EA, McGregor JG, Burkart ME, Poulton CJ, Hu Y, Falk RJ, Hogan SL.

J Autoimmune Dis Rheumatol. 2014 Nov 1;2(3):74-91.

36.

Palladin is upregulated in kidney disease and contributes to epithelial cell migration after injury.

Chang EH, Gasim AH, Kerber ML, Patel JB, Glaubiger SA, Falk RJ, Jennette JC, Otey CA.

Sci Rep. 2015 Jan 9;5:7695. doi: 10.1038/srep07695.

37.

ANCAs are also antimonocyte cytoplasmic autoantibodies.

Jennette JC, Falk RJ.

Clin J Am Soc Nephrol. 2015 Jan 7;10(1):4-6. doi: 10.2215/CJN.11501114. Epub 2014 Dec 16. No abstract available.

38.

PTPN22 R620W polymorphism and ANCA disease risk in white populations: a metaanalysis.

Cao Y, Liu K, Tian Z, Hogan SL, Yang J, Poulton CJ, Falk RJ, Li W.

J Rheumatol. 2015 Feb;42(2):292-9. doi: 10.3899/jrheum.131430. Epub 2014 Dec 1.

39.

Understanding the role of rituximab in ANCA GN: regressing toward the mean.

Pendergraft WF 3rd, Falk RJ.

J Am Soc Nephrol. 2015 Apr;26(4):771-4. doi: 10.1681/ASN.2014100997. Epub 2014 Nov 7. No abstract available.

40.

Reduced CD5(+) CD24(hi) CD38(hi) and interleukin-10(+) regulatory B cells in active anti-neutrophil cytoplasmic autoantibody-associated vasculitis permit increased circulating autoantibodies.

Aybar LT, McGregor JG, Hogan SL, Hu Y, Mendoza CE, Brant EJ, Poulton CJ, Henderson CD, Falk RJ, Bunch DO.

Clin Exp Immunol. 2015 May;180(2):178-88. doi: 10.1111/cei.12483.

41.

Dysregulation of autoantigen genes in ANCA-associated vasculitis involves alternative transcripts and new protein synthesis.

McInnis EA, Badhwar AK, Muthigi A, Lardinois OM, Allred SC, Yang J, Free ME, Jennette JC, Preston GA, Falk RJ, Ciavatta DJ.

J Am Soc Nephrol. 2015 Feb;26(2):390-9. doi: 10.1681/ASN.2013101092. Epub 2014 Jul 24.

42.

Pathogenesis of antineutrophil cytoplasmic autoantibody-mediated disease.

Jennette JC, Falk RJ.

Nat Rev Rheumatol. 2014 Aug;10(8):463-73. doi: 10.1038/nrrheum.2014.103. Epub 2014 Jul 8. Review.

PMID:
25003769
43.

B cell-mediated pathogenesis of ANCA-mediated vasculitis.

Jennette JC, Falk RJ.

Semin Immunopathol. 2014 May;36(3):327-38. doi: 10.1007/s00281-014-0431-y. Epub 2014 Apr 29. Review.

44.

Predictors of treatment outcomes in ANCA-associated vasculitis with severe kidney failure.

Lee T, Gasim A, Derebail VK, Chung Y, McGregor JG, Lionaki S, Poulton CJ, Hogan SL, Jennette JC, Falk RJ, Nachman PH.

Clin J Am Soc Nephrol. 2014 May;9(5):905-13. doi: 10.2215/CJN.08290813. Epub 2014 Feb 27.

45.

A pilot study of leukocyte expression patterns for drug metabolizing enzyme and transporter transcripts in autoimmune glomerulonephritis.

Joy MS, Roberts BV, Wang J, Hu Y, Hogan SL, Falk RJ.

Int J Clin Pharmacol Ther. 2014 Apr;52(4):303-13. doi: 10.5414/CP201972.

46.

Sickle trait in African-American hemodialysis patients and higher erythropoiesis-stimulating agent dose.

Derebail VK, Lacson EK Jr, Kshirsagar AV, Key NS, Hogan SL, Hakim RM, Mooney A, Jani CM, Johnson C, Hu Y, Falk RJ, Lazarus JM.

J Am Soc Nephrol. 2014 Apr;25(4):819-26. doi: 10.1681/ASN.2013060575. Epub 2014 Jan 23.

47.

Clinical characteristics and outcome of pauci-immune glomerulonephritis in African Americans.

Geetha D, Poulton CJ, Hu Y, Seo P, McGregor JA, Falk RJ, Hogan SL.

Semin Arthritis Rheum. 2014 Jun;43(6):778-83. doi: 10.1016/j.semarthrit.2013.11.011. Epub 2013 Dec 4.

48.

Personalized prophylactic anticoagulation decision analysis in patients with membranous nephropathy.

Lee T, Biddle AK, Lionaki S, Derebail VK, Barbour SJ, Tannous S, Hladunewich MA, Hu Y, Poulton CJ, Mahoney SL, Charles Jennette J, Hogan SL, Falk RJ, Cattran DC, Reich HN, Nachman PH.

Kidney Int. 2014 Jun;85(6):1412-20. doi: 10.1038/ki.2013.476. Epub 2013 Dec 11.

49.

C5a receptor (CD88) blockade protects against MPO-ANCA GN.

Xiao H, Dairaghi DJ, Powers JP, Ertl LS, Baumgart T, Wang Y, Seitz LC, Penfold ME, Gan L, Hu P, Lu B, Gerard NP, Gerard C, Schall TJ, Jaen JC, Falk RJ, Jennette JC.

J Am Soc Nephrol. 2014 Feb;25(2):225-31. doi: 10.1681/ASN.2013020143. Epub 2013 Oct 31.

50.

Single-item or two-item literacy screener to predict the S-TOFHLA among adult hemodialysis patients.

Brice JH, Foster MB, Principe S, Moss C, Shofer FS, Falk RJ, Ferris ME, DeWalt DA.

Patient Educ Couns. 2014 Jan;94(1):71-5. doi: 10.1016/j.pec.2013.09.020. Epub 2013 Oct 12.

PMID:
24169024

Supplemental Content

Support Center